ProKidney News

Buy Rating Affirmed for ProKidney Amidst Strategic Clinical Advancements and Solid Financial Outlook

TipRanksMar 23 10:36 ET

ProKidney Analyst Ratings

BenzingaMar 7 04:20 ET

Analysts Conflicted on These Healthcare Names: ProKidney (PROK), Gritstone Oncology (GRTS) and MicroPort Scientific (OtherMCRPF)

TipRanksMar 6 06:20 ET

BTIG Reaffirms Their Buy Rating on ProKidney (PROK)

TipRanksJan 2 09:32 ET

B of A Securities Downgrades ProKidney to Neutral, Lowers Price Target to $2

BenzingaJan 2 09:08 ET

ProKidney Analyst Ratings

BenzingaJan 2 09:05 ET

Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN), Palatin Technologies (PTN) and ProKidney (PROK)

TipRanksNov 15, 2023 07:31 ET

ProKidney's Future Promising: REACT Trial Success and Strategic Enrollment Shift Boosts Buy Rating

TipRanksNov 15, 2023 06:23 ET

BTIG Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $16

BenzingaJul 25, 2023 04:32 ET

ProKidney Analyst Ratings

BenzingaJul 25, 2023 04:31 ET

Analysts Offer Insights on Healthcare Companies: ProKidney (PROK) and Enliven Therapeutics (ELVN)

TipRanksMay 12, 2023 08:10 ET

Jefferies Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $15

Benzinga Real-time NewsDec 21, 2022 06:21 ET

Morgan Stanley Initiates Coverage On ProKidney With Equal-Weight Rating, Announces Price Target of $13

Benzinga Real-time NewsNov 10, 2022 08:02 ET

UBS Initiates Coverage on ProKidney With Buy Rating, $18 Price Target

MT NewswiresOct 18, 2022 12:06 ET

BofA Securities Starts ProKidney at Buy With $14 Price Target

MT NewswiresSep 23, 2022 06:26 ET

ProKidney Analyst Ratings

Benzinga Analyst RatingsSep 2, 2022 09:34 ET